Cargando…
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
Some patients treated with dual antiplatelet therapy (DAPT) following acute coronary syndrome (ACS) can still exhibit heightened residual platelet reactivity (HRPR), which is potentially linked to adverse vascular outcomes. Better tailored DAPT strategies are needed to address this medical need. Aim...
Autores principales: | Lomakin, Nikita, Rudakova, Anna, Buryachkovskaya, Liudmila, Serebruany, Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950204/ https://www.ncbi.nlm.nih.gov/pubmed/31933687 http://dx.doi.org/10.15420/ecr.2018.29.2 |
Ejemplares similares
-
Validating the Prognostic Utility of the ABCD-GENE Score in Asian Patients with Acute Coronary Syndrome Patients on Clopidogrel
por: Tan, Cheng Keat, et al.
Publicado: (2023) -
Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?
por: Godoy, Lucas C, et al.
Publicado: (2019) -
A Practical Guide for Cardiologists to the Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease
por: Ahmad, Tariq, et al.
Publicado: (2021) -
The Effect of Statins on the Functionality of CD4+CD25+FOXP3+ Regulatory T-cells in Acute Coronary Syndrome: A Systematic Review and Meta-analysis of Randomised Controlled Trials in Asian Populations
por: Sorathia, Nilofer, et al.
Publicado: (2019) -
STOMp: sexual function trial of overactive bladder medication
por: Polland, Allison, et al.
Publicado: (2023)